Vogenx Inc.

NASDAQ: VOGX · Healthcare · Biotechnology

PublicHQ Raleigh, NC · WakeReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS —

v0.1 · 0/100 weight · pillars only

↑ listing tenure · ↓ listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-18

Market cap

—

as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Vogenx Inc.’s financial profile?

Vogenx Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Apnimed, Inc.——Attovia Therapeutics, Inc.——BlossomHill Therapeutics, Inc.——LifePoint, Inc.——Plant-Based Investment Corp.——

Neighbors

Wake →

Martin Marietta Materials, Inc.$6.2B80B+First Citizens BancShares, Inc.$9.5B50D Liquidia Corporation$158.3M59C Ralliant Corp$2.1B40D Enact Holdings Inc.$1.2B67B Vontier Corporation$3.1B66B

Key facts

CEOJames Green

SectorHealthcare

IndustryBiotechnology

HeadquartersRaleigh, NC

ExchangeNASDAQ: VOGX

Employees—

IPO date2026-08-12

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.